S
Shuai-Shuai Gong
Researcher at China Pharmaceutical University
Publications - 3
Citations - 72
Shuai-Shuai Gong is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Blood–brain barrier & Tissue plasminogen activator. The author has an hindex of 2, co-authored 3 publications receiving 14 citations.
Papers
More filters
Journal ArticleDOI
Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.
TL;DR: Wang et al. as mentioned in this paper found that TCM has the potential to prevent and treat the coronavirus disease-2019 (COVID-19), which has aroused great concern from the international community.
Journal ArticleDOI
Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.
Shuai-Shuai Gong,Guosheng Cao,Guosheng Cao,Fang Li,zhuo Chen,Xue-wei Pan,Huifen Ma,Yuanyuan Zhang,Boyang Yu,Junping Kou +9 more
TL;DR: In this article, the breakdown of the blood-brain barrier (BBB) aggravates brain damage, and endothelial detachment contributes to BBB disruption and neurovascular dysfunction.
Journal ArticleDOI
YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
Xue-wei Pan,Mei-Juan Wang,Shuai-Shuai Gong,Minhui Sun,Yan Wang,Yuanyuan Zhang,Fang Li,Boyang Yu,Junping Kou +8 more
TL;DR: YQFM suppressed tPA-induced HT by inhibiting cytoskeletal rearrangement linked with ROCK-cofilin/MLC pathways and inhibiting the nuclear factor-kappa B pathway to ameliorate BBB damage caused by tPA.